CorrespondenceStatistical treatment of withdrawal in trials of anti-dementia drugs
References (5)
- et al.
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
Lancet
(2008) - et al.
Dimebon in Alzheimer's disease: old drug for new indication
Lancet
(2008)
There are more references available in the full text version of this article.
Cited by (3)
Molecular targets in the rational design of AD specific pet tracers: Tau or amyloid aggregates?
2011, Current Alzheimer ResearchHow should we deal with missing data in clinical trials involving alzheimer's disease patients?
2011, Current Alzheimer Research
Copyright © 2008 Elsevier Ltd. All rights reserved.